Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MED29 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RTFDC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CIAPIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPATCH2L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX10 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIR21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF103-CHMP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
LEPROT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPS30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GCNT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP192 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRICKLE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNC1LI2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TCAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYM - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AP1G1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IKBKB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PEX3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on